Thyroid eye disease: What should optometrists know? (C-100503)

CPD
1
11 December 2020
Volume 21, Issue 4

This review aims to inform readers about thyroid eye disease.

Domains covered

Communication Clinical practice
Thyroid eye disease (TED) is an autoimmune condition in which the immune system becomes mistakenly activated against the patient’s own orbital tissues, causing inflammation and swelling. TED is relatively rare, affecting around 25 of every 100,000 people in the UK, so optometrists may not see many cases in their careers. However, TED is important because it is a very distressing condition that can threaten eyesight and alter facial appearance enough to cause permanent disfigurement if not treated. This review aims to inform readers about TED, and in particular to enable optometrists to recognise TED, to advise patients and recommend supportive treatment, to make appropriate onward referrals and to identify some of the treatments patients may receive after specialist referral.

Sign in to continue

Forgotten password?
Register

Sign in to view the article

Not a member? Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.

Related further reading

This online therapeutics peer review session is open to College members who are qualified independent prescribers or studying for an IP qualification.

This online therapeutics peer review session is open to College members who are qualified independent prescribers or studying for an IP qualification.